This afternoon, the #EARLYSCAN Cluster Meeting focused on dedicated working groups, shaping the next 12 months of collaboration. Partners have worked together to define shared priorities, communication outputs & policy recommendations to support Europe’s Cancer Mission goals. 🇪🇺 #HaDEA

Buongiorno da Pompei 🇮🇹 #DISARM is delighted to join fellow #EARLYSCAN projects for the 1st Annual Cluster Meeting, exploring how data, citizen engagement, inequalities & scientific collaboration can support Europe’s Cancer Mission. 🎗️ #HaDEA #HorizonEurope

DISARM was proud to be represented at the IARC@60 conference with a scientific poster on ovarian cancer risk assessment and early detection 💙 The event highlighted the power of science & public health action to reduce cancer burden worldwide. #HaDEA #CancerMission

Just days to go until the first in-person EARLYSCAN cluster meeting in Pompeii 🏛️ DISARM EU, PREDI-LYNCH, and the SHIELD project partners will come together to strengthen collaboration on earlier detection of heritable cancers 💙 Learn more: disarm-project.eu/2026/02/03/p... #HaDEA #CancerMission

The EARLYSCAN cluster — comprised of the DISARM, PREDI-LYNCH, & SHIELD projects — is looking forward to our first in-person meeting in Pompeii 🏛️ Stay tuned as we work together to advance earlier detection of heritable cancers 💙 💻 Learn more: disarm-project.eu/2026/02/03/p... #HaDEA #CancerMission

Today on World Ovarian Cancer Day, we stand with all those affected and highlight the importance of awareness and early detection 🔬 Through DISARM, we’re improving risk assessment to support earlier diagnosis across Europe 💙 🔗 Find out how here: disarm-project.eu #HaDEA #CancerMission

In a guest blog ahead of World Ovarian Cancer Day on May 8th, our partners at the World Ovarian Cancer Coalition highlight the importance of visibility, storytelling, and collective action through #ReachForTheScars. 💻 Read the full piece on our website here: disarm-project.eu/2026/05/01/r...

Over 320,000 women are diagnosed with ovarian cancer globally each year (World Cancer Research Fund) Too many cases are still detected late, with serious impacts on survival. 💻 Learn how DISARM improves early detection & research: disarm-project.eu #HaDEA #CancerMission

🎬 New video from DISARM! We’re tackling key challenges in ovarian cancer - from personalised risk assessment to early detection - through collaboration across Europe. youtube.com/watch?v=mqQk... #HaDEA #CancerMission

On #WorldHealthDay 2026, we recognise the dedication of healthcare professionals worldwide 🩺 “Together for health. Stand with science” reflects the power of collaboration at the heart of DISARM. We also stand with all those impacted by ovarian cancer 💙 #CancerMission #HaDEA

The first DISARM Newsletter is here! 📩 In the first edition, we’re sharing highlights from our first 6 months — from project launch and collaboration to early research progress in ovarian cancer detection 💙 disarm-project.eu/2026/03/31/d... #HaDEA #CancerMission

Missed this last week? ESGO is calling for systemic reform in women’s cancer care across Europe, and DISARM is already helping move that forward 🩺 Read more: disarm-project.eu/2026/03/03/a... #HaDEA #CancerMission

Happy to see DISARM featured with the outlet It’s Possible! 📰 The piece highlights the strength of our international team, and how we are working to detect hereditary ovarian cancer early using AI, liquid biopsies, and genetic insights 🧬 Read the full story here: www.itspossible.gr/%CE%B4%CE%B9...

"If ovaries were visible, would policy see them?" Last week, our partner Christel Paganoni-Bruijns of the World Ovarian Cancer Coalition joined The Parliament Magazine's #IWD Talks on gynecological cancers in Europe. Ovarian cancer must be visible in EU health policy!

Today on #InternationalWomensDay, we celebrate the incredible women of DISARM, and honour the strength of patients and families whose courage inspires our work💙 Happy International Women's Day! 👩‍🏫👩‍💼👩‍🔬 #HaDEA #CancerMission

🎥 Final interview from the DISARM kick-off in Athens! 🇬🇷 Project Coordinator @dimitra-dionysiou.bsky.social shares her role, what excites her about the project, and the consortium’s ambitious goals. Watch now 🎬 #HaDEA #CancerMission www.youtube.com/watch?v=ZWjX...

Pleased to see the launch of the EARLYSCAN cluster featured by @ascopost.bsky.social 📰 Bringing together DISARM EU, PREDI-LYNCH, and SHIELD, EARLYSCAN is strengthening cross-country collaboration to advance early detection of heritable cancers. Read more below 🔗 ascopost.com/news/februar...

Today, DISARM joined #AthensDigitalHealthWeek 2026's Cancer Track roundtable on early detection & personalised cancer care 👨‍🏫 Coordinator @dimitra-dionysiou.bsky.social discussed integrating AI, biomarkers & risk models into national screening, and ensuring equitable access across the EU 💙

Great to see DISARM at Athens Digital Health Week's Early Screening & Hereditary Cancer Awareness session 🧬 Featured DISARM EU, SHIELD, & PREDI-LYNCH showcasing collaboration on early detection of heritable cancers. Thanks to @dimitra-dionysiou.bsky.social for representing the project 👏

🚨 Athens Digital Health Week, Mon 16th! The EARLYSCAN Cluster is hosting a hands-on workshop: "Early Detection & Personalised Cancer Care" Digital health/AI/cancer folks - join us & help shape the future! athensdigitalhealth.eu #HaDEA #CancerMission #AthensDigitalHealthWeek

A new @politico.eu article highlights the rising burden & the need for action on ovarian cancer, featuring DISARM as a promising step toward earlier detection and better risk assessment 🩺 #HaDEA #CancerMission 🔗 www.politico.eu/sponsored-co...

Introducing EARLYSCAN: a new EU cluster uniting projects DISARM, PREDI-LYNCH & SHIELD to advance early detection of heritable cancers 🎗️ By coordinating research across countries & cancer types, we're accelerating progress for people at genetic risk. 🔗 disarm-project.eu/2026/02/03/p...

On #WorldCancerDay, DISARM highlights the urgent challenge of #OvarianCancer — often diagnosed late, with limited early detection options. Find out how we are working to improve risk assessment & early detection 🔍 🔗 disarm-project.eu/2026/01/29/w... #HaDEA #CancerMission

The Lancet Commission on Ovarian Cancer calls for earlier identification of women at increased risk, including genetic testing and personalised risk tools, aligning closely with DISARM’s focus on early detection 🧬 #HaDEA #CancerMission www.thelancet.com/journals/lan...

Proud to see DISARM featured in the latest newsletter from our partner the World Ovarian Cancer Coalition, as part of their reflections on 2026 and the next decade of action on ovarian cancer 💙 Check out the full newsletter below! 🗞️ #HaDEA #CancerMission

DISARM partner VOC Diagnostics helps to show that ovarian cancer can be detected from blood plasma using an AI-driven electronic nose - no biomarkers needed. Exactly the innovation we need for earlier detection 💙 🔗Read more: researchgate.net/publication/... #HaDEA #CancerMission

🎥 DISARM Interview Series – Episode 3 We spoke with Fatima Vaz on IPOLisboa’s role in DISARM, her expertise as a medical oncologist, and the innovative technologies being tested as part of the project. 🎬 Watch: youtu.be/Hpjs6EqzfdE #HaDEA #CancerMission

🎥 Our second DISARM interview video is live! In this video, Laura Caretto of EVITA discusses her role in the project, the project's Citizen Awareness Campaign, and what she is most excited about as DISARM moves forward. 🎬 Watch the interview here: youtu.be/i3pRl4qngjY?... #HaDEA #CancerMission

🎁 It’s time to unwrap our Christmas present! The official DISARM project website is now live — bringing together our mission, partners & progress in one place. 🔗 Visit: Home | disarm-project.eu #HaDEA #CancerMission

🎅 An early holiday surprise… The DISARM project’s official website is launching very soon, bringing together all our project information, project partners, and updates in one place. Stay tuned — the wrapping is coming off shortly! 🎁 #HaDEA #CancerMission

Our partner, the World Ovarian Cancer Coalition, has released the first findings of the Every Woman Study: LMIC Edition — revealing critical disparities in awareness, diagnosis, and access to care for the majority of women worldwide living with ovarian cancer 📄 www.thelancet.com/journals/lan...

📄 We're proud to share that Jens Eriksson, a DISARM partner with VOC Diagnostics, co-authored a study showing ML-driven VOC analysis can detect ovarian & endometrial cancer with high accuracy - even early. Includes refinements for DISARM’s OVA-VOC assay. www.sciencedirect.com/science/arti...

We’re pleased to share that Zdenek Kleibl of @charlesuni.cuni.cz took part in the 2025 CSBMB Annual Symposium in Nanchang, China (23–26 Oct). He also presented the DISARM project, sharing its goals and research with an international audience. 📸 Photos below! #HaDEA #CancerMission

🎥 Our first DISARM interview is live! The video features Clara MacKay, CEO of the World Ovarian Cancer Coalition, who shares her role in the project & what excites her most about DISARM’s mission to advance early detection. Watch here 👇 youtube.com/watch?v=Iwn7vzSuRZA&feature=youtu.be

Knowing the symptoms of #OvarianCancer can save lives — please take a moment to watch and share @targetovarian.bsky.social's video over on X and visit their website so more people can recognise the signs early. 💙 #HaDEA #CancerMission x.com/i/status/199...

We were thrilled to present the DISARM project at IPO Lisbon on 31st October! 🎉 If you weren’t able to attend but want to learn more, please feel free to contact the Communication and Dissemination Manager, Ben Moore, at [email protected] #HaDEA #CancerMission

We are proud to share that the @cancerletter.com has featured the first press release from DISARM 📰 A big thank you to them for helping spread word of our project that aims to advance early detection & risk assessment for ovarian cancer 💙 #HaDEA #CancerMission cancerletter.com/clinical-rou...

On October 31, the DISARM project will be presented at the IPO Lisbon Research Meeting, introducing a major step forward in the early detection of ovarian cancer. ✍️Sign up here: lnkd.in/dTfRAinJ #HaDEA #CancerMission

We’re proud to share that ecancer, a leading oncology education platform, has featured the first press release from DISARM — our EU-funded project focused on improving risk assessment and early detection in ovarian cancer 📰 #HaDEA #CancerMission ecancer.org/en/news/2717...

The DISARM project was recently featured on Portugal’s national TV channel RTP, highlighting efforts to improve early detection of ovarian cancer. 💙 Watch the full piece here 👇 www.rtp.pt/noticias/pai...

Exciting news! 📰 The DISARM project has been featured by the Greek outlet Dnews, highlighting the importance of early detection, risk assessment, and smart digital tools for tacking ovarian cancer 💙 www.dnews.gr/eidhseis/sci...

Go behind the scenes of the DISARM project’s official kick-off meeting in Athens! 🎬 See the collaboration, energy, and shared commitment driving our mission to transform ovarian cancer risk assessment and early detection 💙 www.youtube.com/watch?v=xvrm...

That’s a wrap on the #DISARM kick-off in Athens! 2 days of collaboration, keynotes & big ideas: 🏛️ Ovarian cancer socioececonomic burden & the CanRisk tool 🔬 Liquid biopsy & clinical studies 🧬 PRS adaptation 👥 Citizen awareness & Platforms An Exciting journey ahead , thank you to all partners! 💙

Day 2 of the #DISARM kick-off in Athens! 🏛️ We open with a keynote from Prof. Antonis Antoniou (University of Cambridge) on the CanRisk tool. Today’s agenda: risk assessment in clinical studies, citizen awareness, strategies for adapting PRS to national populations and more!

Day 1 of the #DISARM kick-off is complete! 🚀 This afternoon, partners aligned on clinical protocols and explored opportunities for policy development. More updates coming tomorrow, stay tuned!

A busy and engaging morning here in Athens, with an insightful keynote presentation from Clara MacKay on the socioeconomic burden of ovarian cancer 📰 This was followed by a fruitful discussion on liquid biopsy detection from our partners UNRF 👨‍🏫 Stay tuned for more updates throughout the day!

καλημέρα από Αθήνα 🇬🇷 This morning our Project Partners have gathered in Greece for the Disarm kick off meeting. This morning's highlight is a keynote presentation from the World Ovarian Cancer Coalition on ‘The Socioeconomic Burden of Ovarian Cancer’. ⚕️ ➡️ Follow for more updates!

The DISARM consortium is looking forward to meeting in Athens on 2–3 October for our official kick-off! 🇬🇷 We’re bringing partners together from across Europe to set the stage for advancing ovarian cancer risk assessment & early detection 🧬 Stay tuned for updates from Athens!

We’re excited to see a piece on DISARM featured with @imperialcollegeldn.bsky.social's Imperial News, showcasing our mission to tackle ovarian cancer through better risk assessment and early detection 📰 🔗 Read the full feature here: www.imperial.ac.uk/news/268373/...

A huge thanks to the @ec.europa.eu for spotlighting the launch of DISARM in their European Cancer Mission Implementation newsletter! 📰 It was wonderful to be featured alongside so many amazing projects under the EU's Cancer Mission 💙 ec.europa.eu/newsroom/rtd...